Magnite, Inc. (MGNI) stock
Close on Nov 18, 2026Market cap $3.97BP/E 26.4Yield –
Earnings
Magnite's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Magnite's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 24, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 4, 2026after the close | $204.20M | +13.8% | $0.23 | $0.33 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026after the close | $192.80M | +11.3% | $0.13 | $0.26 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 6, 2026after the close | $164.40M | +5.5% | – | $0.13 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 25, 2026after the close | $205.40M | +5.9% | $0.80 | $0.34 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025after the close | $179.50M | +10.8% | $0.13 | $0.20 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025after the close | $173.30M | +6.4% | $0.08 | $0.20 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025after the close | $155.80M | +4.4% | – | $0.12 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025after the close | $194.00M | +3.8% | $0.24 | $0.34 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024after the close | $162.00M | +7.9% | – | $0.17 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024after the close | $162.90M | +6.8% | -$0.01 | $0.14 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 8, 2024after the close | $149.30M | +14.7% | -$0.13 | $0.05 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 28, 2024after the close | $186.90M | +6.6% | $0.16 | $0.29 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 8, 2023after the close | $150.10M | +2.9% | -$0.13 | $0.12 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 9, 2023after the close | $152.50M | +10.7% | -$0.54 | $0.09 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 10, 2023after the close | $130.20M | +10.2% | -$0.73 | $0.04 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 22, 2023after the close | $175.40M | +8.7% | -$0.27 | $0.24 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 9, 2022after the close | $145.80M | +10.5% | -$0.18 | $0.18 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022after the close | $137.80M | – | -$0.19 | $0.14 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 4, 2022after the close | $118.10M | – | -$0.34 | $0.08 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 23, 2022after the close | $161.30M | – | $0.00 | $0.26 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 3, 2021after the close | $131.90M | – | -$0.18 | $0.14 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 5, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 10, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 5, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 9, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Magnite's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Adjusted EBITDA operating expensesnon-GAAP | Q4 FY2026 | $125.00M – $127.00M | – | Raised | Nov 4, 2026 |
| Contribution ex-TAC attributable to CTVnon-GAAP | Q4 FY2026 | $124.00M – $127.00M | – | Lowered | Nov 4, 2026 |
| Contribution ex-TAC attributable to DV+non-GAAP | Q4 FY2026 | $103.00M – $106.00M | – | Lowered | Nov 4, 2026 |
| Total Contribution ex-TACnon-GAAP | Q4 FY2026 | $227.00M – $233.00M | – | New | Nov 4, 2026 |
| Adjusted EBITDA marginnon-GAAP | FY2026 | 37% | 35.5% | Raised | Aug 5, 2026 |
| Adjusted EBITDA (1) percentage growthnon-GAAP | FY2026 | +20% | – | New | Aug 5, 2026 |
| Adjusted EBITDA marginnon-GAAP | FY2026 | 38.5% | – | New | Nov 4, 2026 |
| Adjusted EBITDA percentage growthnon-GAAP | FY2026 | +30% | – | New | Nov 4, 2026 |
| free cash flow growthnon-GAAP | FY2026 | +60% | – | New | Nov 4, 2026 |
| Free cash flow growthnon-GAAP | FY2026 | +30% | – | New | Feb 25, 2026 |
| Capex | FY2026 | $60.00M | – | New | Feb 25, 2026 |
| Adjusted EBITDA marginnon-GAAP | FY2026 | 35% | – | New | Feb 25, 2026 |
| total Contribution ex-TAC (1) growthnon-GAAP | FY2026 | +13% – +14% | +11% | Raised | Aug 5, 2026 |
| total Contribution ex-TAC growthnon-GAAP | FY2026 | +17% | – | New | Nov 4, 2026 |
| Total top-line growth on a total reported basisGAAP | FY2027 | +10% | – | New | Nov 4, 2026 |
| Total top-line growth, excluding politicalnon-GAAP | FY2027 | +15% | – | New | Nov 4, 2026 |
| Adjusted EBITDA marginnon-GAAP | FY2027 | 38.5% | – | New | Nov 4, 2026 |
Guidance history
Every forecast Magnite put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 4, 2026 | Adjusted EBITDA percentage growth | FY2026 | +30% | New |
| Nov 4, 2026 | Adjusted EBITDA margin | FY2026 | 38.5% | New |
| Nov 4, 2026 | Adjusted EBITDA margin | FY2027 | 38.5% | New |
| Nov 4, 2026 | free cash flow growth | FY2026 | +60% | New |
| Nov 4, 2026 | total Contribution ex-TAC growth | FY2026 | +17% | New |
| Nov 4, 2026 | Contribution ex-TAC attributable to DV+ | Q4 FY2026 | $103.00M – $106.00M | Lowered |
| Nov 4, 2026 | Total Contribution ex-TAC | Q4 FY2026 | $227.00M – $233.00M | New |
| Nov 4, 2026 | Contribution ex-TAC attributable to CTV | Q4 FY2026 | $124.00M – $127.00M | Lowered |
| Nov 4, 2026 | Adjusted EBITDA operating expenses | Q4 FY2026 | $125.00M – $127.00M | Raised |
| Nov 4, 2026 | Total top-line growth on a total reported basis | FY2027 | +10% | New |
| Nov 4, 2026 | Total top-line growth, excluding political | FY2027 | +15% | New |
| Aug 5, 2026 | Adjusted EBITDA (1) percentage growth | FY2026 | +20% | New |
| Aug 5, 2026 | Adjusted EBITDA margin | FY2026 | 37% | Raised |
| Aug 5, 2026 | Contribution ex-TAC (1) attributable to DV+ | Q3 FY2026 | $90.00M – $92.00M | Lowered |
| Aug 5, 2026 | total Contribution ex-TAC (1) growth | FY2026 | +13% – +14% | Raised |
| Aug 5, 2026 | Total Contribution ex-TAC | Q3 FY2026 | $188.00M – $192.00M | New |
| Aug 5, 2026 | Contribution ex-TAC (1) attributable to CTV | Q3 FY2026 | $98.00M – $100.00M | Lowered |
| Aug 5, 2026 | Adjusted EBITDA operating expenses | Q3 FY2026 | $119.00M – $121.00M | Raised |
| May 6, 2026 | Adjusted EBITDA margin | FY2026 | 35.5% | Raised |
| May 6, 2026 | total Contribution ex-TAC growth | FY2026 | +11% | Reaffirmed |
| May 6, 2026 | Total Contribution ex-TAC | Q2 FY2026 | $177.00M – $181.00M | New |
| May 6, 2026 | Contribution ex-TAC attributable to CTV | Q2 FY2026 | $90.00M – $92.00M | Lowered |
| May 6, 2026 | Contribution ex-TAC attributable to DV+ | Q2 FY2026 | $87.00M – $89.00M | Lowered |
| May 6, 2026 | Adjusted EBITDA operating expenses | Q2 FY2026 | $115.00M – $117.00M | Raised |
| Feb 25, 2026 | Capex | FY2026 | $60.00M | New |
| Feb 25, 2026 | Free cash flow growth | FY2026 | +30% | New |
| Feb 25, 2026 | Total Contribution ex-TAC growth | FY2026 | +11% | Reaffirmed |
| Feb 25, 2026 | Total Contribution ex-TAC | Q1 FY2026 | $157.00M – $161.00M | New |
| Feb 25, 2026 | Adjusted EBITDA margin | FY2026 | 35% | New |
| Feb 25, 2026 | Contribution ex-TAC (1) attributable to DV+ | Q1 FY2026 | $76.00M – $78.00M | Lowered |
| Feb 25, 2026 | Adjusted EBITDA operating expenses | Q1 FY2026 | $122.00M | Raised |
| Feb 25, 2026 | Contribution ex-TAC (1) attributable to CTV | Q1 FY2026 | $81.00M – $83.00M | Lowered |
| Nov 5, 2025 | Adjusted EBITDA margin expansion | FY2025 | 180 | New |
| Nov 5, 2025 | Adjusted EBITDA margin | FY2026 | 35% | New |
| Nov 5, 2025 | total Contribution ex-TAC growth | FY2025 | +10% | New |
| Nov 5, 2025 | Total Contribution ex-TAC growth | Q4 FY2025 | +6% – +9% | New |
| Nov 5, 2025 | Total Contribution ex-TAC growth excluding political | Q4 FY2025 | +13% – +16% | Raised |
| Nov 5, 2025 | Contribution ex-TAC attributable to CTV growth | Q4 FY2025 | +12% – +14% | Lowered |
| Nov 5, 2025 | Contribution ex-TAC attributable to CTV growth excluding political | Q4 FY2025 | +23% – +25% | Raised |
| Nov 5, 2025 | Contribution ex-TAC attributable to DV+ | Q4 FY2025 | +104% – +107% | Raised |
| Nov 5, 2025 | Contribution ex-TAC attributable to DV+ growth | Q4 FY2025 | +2% – +5% | Lowered |
| Nov 5, 2025 | Contribution ex-TAC attributable to DV+ growth excluding political | Q4 FY2025 | +7% – +10% | Raised |
| Nov 5, 2025 | Total Contribution ex-TAC | Q4 FY2025 | $191.00M – $196.00M | New |
| Nov 5, 2025 | Contribution ex-TAC attributable to CTV | Q4 FY2025 | $87.00M – $89.00M | Lowered |
| Nov 5, 2025 | Adjusted EBITDA operating expenses | Q4 FY2025 | $112.00M – $114.00M | Raised |
| Nov 5, 2025 | Total Contribution ex-TAC growth | FY2026 | +11% | New |
| Aug 6, 2025 | Total Contribution ex-TAC | Q3 FY2025 | $161.00M – $165.00M | New |
| Aug 6, 2025 | Contribution ex-TAC attributable to CTV | Q3 FY2025 | $71.00M – $73.00M | Lowered |
| Aug 6, 2025 | Contribution ex-TAC attributable to DV+ | Q3 FY2025 | $90.00M – $92.00M | Raised |
| Aug 6, 2025 | Adjusted EBITDA operating expenses | Q3 FY2025 | $109.00M – $111.00M | Raised |
| May 7, 2025 | Total Contribution ex-TAC | Q2 FY2025 | $154.00M – $160.00M | New |
| May 7, 2025 | Contribution ex-TAC attributable to CTV | Q2 FY2025 | $70.00M – $72.00M | Lowered |
| May 7, 2025 | Contribution ex-TAC attributable to DV+ | Q2 FY2025 | $84.00M – $88.00M | Raised |
| May 7, 2025 | Adjusted EBITDA operating expenses | Q2 FY2025 | $110.00M – $112.00M | Raised |
| Feb 26, 2025 | growth in free cash flow | FY2025 | +20% | New |
| Feb 26, 2025 | Adjusted EBITDA margin expansion | FY2025 | 100 | New |
| Feb 26, 2025 | Total Contribution ex-TAC | Q1 FY2025 | $140.00M – $144.00M | New |
| Feb 26, 2025 | Contribution ex-TAC (1) attributable to CTV | Q1 FY2025 | $61.00M – $63.00M | Lowered |
| Feb 26, 2025 | Contribution ex-TAC (1) attributable to DV+ | Q1 FY2025 | $79.00M – $81.00M | Raised |
| Feb 26, 2025 | Adjusted EBITDA operating expenses | Q1 FY2025 | $111.00M – $113.00M | Raised |
| Feb 26, 2025 | Total Contribution ex-TAC growth | FY2025 | +10% | New |
| Nov 7, 2024 | free cash flow growth | FY2024 | +20% | New |
| Nov 7, 2024 | Contribution ex-TAC attributable to CTV growth | Q4 FY2024 | +20% | New |
| Nov 7, 2024 | Total Contribution ex-TAC | Q4 FY2024 | $182.00M – $186.00M | New |
| Nov 7, 2024 | Contribution ex-TAC attributable to CTV | Q4 FY2024 | $75.00M – $77.00M | Lowered |
| Nov 7, 2024 | Contribution ex-TAC attributable to DV+ | Q4 FY2024 | $107.00M – $109.00M | Raised |
| Nov 7, 2024 | Adjusted EBITDA operating expenses | Q4 FY2024 | $102.00M – $104.00M | Lowered |
| Nov 7, 2024 | Contribution ex-TAC growth | FY2024 | +11% – +12% | Raised |
| Aug 7, 2024 | Total capital expenditures | FY2024 | $50.00M | New |
| Aug 7, 2024 | Total Contribution ex-TAC | Q3 FY2024 | $146.00M – $150.00M | New |
| Aug 7, 2024 | Contribution ex-TAC attributable to CTV | Q3 FY2024 | $62.00M – $64.00M | Lowered |
| Aug 7, 2024 | Contribution ex-TAC attributable to DV+ | Q3 FY2024 | $84.00M – $86.00M | Raised |
| Aug 7, 2024 | Adjusted EBITDA operating expenses | Q3 FY2024 | $101.00M – $103.00M | Raised |
| Aug 7, 2024 | Adjusted EBITDA margin expansion | FY2024 | 100 – 150 | Reaffirmed |
| Aug 7, 2024 | Contribution ex-TAC | FY2024 | +10% | Reaffirmed |
| May 8, 2024 | Total Contribution ex-TAC (1) | Q2 FY2024 | $142.00M – $146.00M | Raised |
| May 8, 2024 | Contribution ex-TAC (1) attributable to CTV | Q2 FY2024 | $59.00M – $61.00M | Lowered |
| May 8, 2024 | Contribution ex-TAC (1) attributable to DV+ | Q2 FY2024 | $83.00M – $85.00M | Raised |
| May 8, 2024 | Adjusted EBITDA operating expenses (4) | Q2 FY2024 | $101.00M – $103.00M | Raised |
| May 8, 2024 | Adjusted EBITDA margin (2) expansion | FY2024 | 100 – 150 | Raised |
| May 8, 2024 | Contribution ex-TAC (1) | FY2024 | +10% | Reaffirmed |
| Feb 28, 2024 | Total Contribution ex-TAC | Q1 FY2024 | $122.00M – $126.00M | New |
| Feb 28, 2024 | Contribution ex-TAC attributable to CTV | Q1 FY2024 | $49.00M – $51.00M | Lowered |
| Feb 28, 2024 | Contribution ex-TAC attributable to DV+ | Q1 FY2024 | $73.00M – $75.00M | Raised |
| Feb 28, 2024 | Adjusted EBITDA operating expenses | Q1 FY2024 | $106.00M – $108.00M | Raised |
| Feb 28, 2024 | Adjusted EBITDA operating expenses | Q2 FY2024 | $101.00M – $103.00M | New |
| Feb 28, 2024 | Adjusted EBITDA margin expansion | FY2024 | 100 | New |
| Feb 28, 2024 | Total Contribution ex-TAC growth | FY2024 | +10% | New |
| Nov 8, 2023 | Total Contribution ex-TAC | Q4 FY2023 | $158.00M – $162.00M | New |
| Nov 8, 2023 | Contribution ex-TAC attributable to CTV | Q4 FY2023 | $61.00M – $63.00M | Lowered |
| Nov 8, 2023 | Contribution ex-TAC attributable to DV+ | Q4 FY2023 | $97.00M – $99.00M | Raised |
| Nov 8, 2023 | Adjusted EBITDA operating expenses | Q4 FY2023 | $94.00M – $96.00M | Lowered |
| Aug 9, 2023 | total capital expenditures | FY2023 | $40.00M | New |
| Aug 9, 2023 | free cash flow | FY2023 | $100.00M | Reaffirmed |
| Aug 9, 2023 | Contribution ex-TAC | Q3 FY2023 | $128.00M – $132.00M | New |
| Aug 9, 2023 | Contribution ex-TAC attributable to CTV | Q3 FY2023 | $50.00M – $52.00M | Lowered |
| Aug 9, 2023 | Contribution ex-TAC attributable to DV+ | Q3 FY2023 | $78.00M – $80.00M | Raised |
| Aug 9, 2023 | Adjusted EBITDA operating expenses | Q3 FY2023 | $92.00M – $94.00M | Raised |
| May 10, 2023 | total capital expenditures | FY2023 | $40.00M | Reaffirmed |
| May 10, 2023 | free cash flow | FY2023 | $100.00M | Reaffirmed |
| May 10, 2023 | Revenue ex-TAC attributable to CTV | Q2 FY2023 | $56.00M – $58.00M | New |
| May 10, 2023 | Adjusted EBITDA operating expenses | Q2 FY2023 | $94.00M – $96.00M | Raised |
| May 10, 2023 | Revenue ex-TAC | Q2 FY2023 | $132.00M – $136.00M | New |
| Feb 22, 2023 | Total capital expenditures | FY2023 | $40.00M | New |
| Feb 22, 2023 | Total free cash flow | FY2023 | $100.00M | New |
| Feb 22, 2023 | Revenue ex-TAC attributable to CTV | Q1 FY2023 | $42.50M – $44.50M | New |
| Feb 22, 2023 | Adjusted EBITDA operating expenses | Q1 FY2023 | $92.00M – $94.00M | Raised |
| Feb 22, 2023 | Revenue ex-TAC | Q1 FY2023 | $109.00M – $113.00M | New |
| Nov 9, 2022 | Total capital expenditures | Q4 FY2022 | $9.00M | New |
| Nov 9, 2022 | free cash flow | FY2022 | $105.00M | Raised |
| Nov 9, 2022 | Revenue ex-TAC attributable to CTV | Q4 FY2022 | $63.00M – $65.00M | New |
| Nov 9, 2022 | Adjusted EBITDA operating expenses | Q4 FY2022 | $88.00M – $90.00M | Raised |
| Nov 9, 2022 | Revenue ex-TAC | Q4 FY2022 | $151.00M – $157.00M | New |
| Nov 9, 2022 | revenue ex-TAC | FY2022 | $510.00M | Raised |
| Aug 9, 2022 | Total capital expenditures | FY2022 | $45.00M | Raised |
| Aug 9, 2022 | free cash flow | FY2022 | $100.00M | Reaffirmed |
| Aug 9, 2022 | Revenue ex-TAC attributable to CTV | Q3 FY2022 | $52.00M – $54.00M | New |
| Aug 9, 2022 | Adjusted EBITDA operating expenses | Q3 FY2022 | $85.00M – $87.00M | Raised |
| Aug 9, 2022 | Revenue ex-TAC | Q3 FY2022 | $122.00M – $126.00M | New |
| Aug 9, 2022 | Revenue ex-TAC | FY2022 | $500.00M | Reaffirmed |
| May 4, 2022 | total capital expenditures | FY2022 | $40.00M – $45.00M | Reaffirmed |
| May 4, 2022 | free cash flow | FY2022 | $100.00M | Reaffirmed |
| May 4, 2022 | Adjusted EBITDA operating expenses | Q2 FY2022 | $83.00M – $85.00M | New |
| May 4, 2022 | Revenue ex-TAC | Q2 FY2022 | $123.00M – $127.00M | New |
| May 4, 2022 | Revenue ex-TAC attributable to CTV | Q2 FY2022 | $51.00M – $53.00M | Lowered |
| May 4, 2022 | revenue ex-TAC | FY2022 | $500.00M | Reaffirmed |
| Feb 23, 2022 | Total capital expenditures | FY2022 | $40.00M – $45.00M | New |
| Feb 23, 2022 | Free cash flow | FY2022 | $100.00M | New |
| Feb 23, 2022 | Revenue ex-TAC attributable to CTV | Q1 FY2022 | $40.00M – $42.00M | New |
| Feb 23, 2022 | Adjusted EBITDA operating expenses | Q1 FY2022 | $83.00M – $85.00M | Raised |
| Feb 23, 2022 | Revenue ex-TAC | Q1 FY2022 | $105.00M – $109.00M | New |
| Feb 23, 2022 | Revenue ex-TAC | FY2022 | $500.00M | New |
| Nov 3, 2021 | Total capital expenditures | Q4 FY2021 | $8.00M | New |
| Nov 3, 2021 | Revenue ex-TAC attributable to CTV | Q4 FY2021 | $52.00M – $56.00M | New |
| Nov 3, 2021 | Adjusted EBITDA operating expenses | Q4 FY2021 | $79.00M – $81.00M | Raised |
| Nov 3, 2021 | Revenue ex-TAC | Q4 FY2021 | $138.00M – $142.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Magnite filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Results
See a number that looks wrong?